Clinical Trial Update: Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating second-line chemotherapy with or without bevacizumab for metastatic colorectal cancer in patients who previously received first-line …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Colorectal Cancer | Phase 3 | Status: TERMINATED